Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPS: Teduglutide in SBS
NCT00798967Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2008
- Primary completion
- Jan 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Nov 2008; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT00798967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798967.